nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ALB—Vismodegib—skin cancer	0.121	0.153	CbGbCtD
Levothyroxine—SLCO1B3—Docetaxel—skin cancer	0.103	0.13	CbGbCtD
Levothyroxine—ALB—Vemurafenib—skin cancer	0.0955	0.121	CbGbCtD
Levothyroxine—CYP2C8—Vismodegib—skin cancer	0.0934	0.118	CbGbCtD
Levothyroxine—ABCB1—Vismodegib—skin cancer	0.0632	0.0801	CbGbCtD
Levothyroxine—CYP3A4—Temozolomide—skin cancer	0.0546	0.0692	CbGbCtD
Levothyroxine—CYP3A4—Imiquimod—skin cancer	0.0546	0.0692	CbGbCtD
Levothyroxine—ALB—Fluorouracil—skin cancer	0.0429	0.0544	CbGbCtD
Levothyroxine—CYP3A4—Vismodegib—skin cancer	0.0379	0.048	CbGbCtD
Levothyroxine—ABCB1—Dactinomycin—skin cancer	0.0332	0.0421	CbGbCtD
Levothyroxine—CYP2C8—Fluorouracil—skin cancer	0.0332	0.042	CbGbCtD
Levothyroxine—CYP3A4—Vemurafenib—skin cancer	0.0299	0.0379	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—skin cancer	0.0171	0.0217	CbGbCtD
Levothyroxine—CYP3A4—Docetaxel—skin cancer	0.0103	0.013	CbGbCtD
Levothyroxine—SERPINA7—neck—skin cancer	0.00576	0.0786	CbGeAlD
Levothyroxine—Infertility—Temozolomide—skin cancer	0.00544	0.0396	CcSEcCtD
Levothyroxine—SLCO4C1—nipple—skin cancer	0.00375	0.0512	CbGeAlD
Levothyroxine—THRB—neck—skin cancer	0.00356	0.0486	CbGeAlD
Levothyroxine—THRA—neck—skin cancer	0.00356	0.0486	CbGeAlD
Levothyroxine—SLC16A2—neck—skin cancer	0.00322	0.044	CbGeAlD
Levothyroxine—Dehydration—Vismodegib—skin cancer	0.00304	0.0221	CcSEcCtD
Levothyroxine—SLC7A5—nipple—skin cancer	0.00274	0.0375	CbGeAlD
Levothyroxine—TTR—neck—skin cancer	0.00264	0.0361	CbGeAlD
Levothyroxine—Weight decreased—Vismodegib—skin cancer	0.00255	0.0186	CcSEcCtD
Levothyroxine—THRA—connective tissue—skin cancer	0.00255	0.0348	CbGeAlD
Levothyroxine—SLCO4A1—nipple—skin cancer	0.0024	0.0327	CbGeAlD
Levothyroxine—SLCO4C1—mammalian vulva—skin cancer	0.00219	0.0299	CbGeAlD
Levothyroxine—Alopecia—Vismodegib—skin cancer	0.002	0.0145	CcSEcCtD
Levothyroxine—SLC7A5—connective tissue—skin cancer	0.00195	0.0266	CbGeAlD
Levothyroxine—TTR—connective tissue—skin cancer	0.0019	0.0259	CbGeAlD
Levothyroxine—SLC7A5—epithelium—skin cancer	0.00185	0.0252	CbGeAlD
Levothyroxine—THRA—female reproductive system—skin cancer	0.0018	0.0246	CbGeAlD
Levothyroxine—THRB—female reproductive system—skin cancer	0.0018	0.0246	CbGeAlD
Levothyroxine—Cardiac failure—Imiquimod—skin cancer	0.00176	0.0128	CcSEcCtD
Levothyroxine—SLC7A5—skin of body—skin cancer	0.00176	0.024	CbGeAlD
Levothyroxine—Menstruation irregular—Docetaxel—skin cancer	0.00171	0.0124	CcSEcCtD
Levothyroxine—Arthralgia—Vismodegib—skin cancer	0.00167	0.0122	CcSEcCtD
Levothyroxine—Irritability—Imiquimod—skin cancer	0.00164	0.0119	CcSEcCtD
Levothyroxine—Wheezing—Bleomycin—skin cancer	0.00164	0.0119	CcSEcCtD
Levothyroxine—SLC7A5—mammalian vulva—skin cancer	0.0016	0.0219	CbGeAlD
Levothyroxine—Weight decreased—Vemurafenib—skin cancer	0.00158	0.0115	CcSEcCtD
Levothyroxine—THRB—head—skin cancer	0.0015	0.0205	CbGeAlD
Levothyroxine—THRA—head—skin cancer	0.0015	0.0205	CbGeAlD
Levothyroxine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00146	0.0106	CcSEcCtD
Levothyroxine—Sweating increased—Imiquimod—skin cancer	0.00145	0.0105	CcSEcCtD
Levothyroxine—SLC7A5—lymphoid tissue—skin cancer	0.00142	0.0194	CbGeAlD
Levothyroxine—SLCO4A1—mammalian vulva—skin cancer	0.0014	0.0191	CbGeAlD
Levothyroxine—TTR—lymphoid tissue—skin cancer	0.00139	0.0189	CbGeAlD
Levothyroxine—Fatigue—Vismodegib—skin cancer	0.00138	0.0101	CcSEcCtD
Levothyroxine—SLC7A5—female reproductive system—skin cancer	0.00137	0.0187	CbGeAlD
Levothyroxine—Disorientation—Bleomycin—skin cancer	0.00137	0.00994	CcSEcCtD
Levothyroxine—SLC16A2—head—skin cancer	0.00136	0.0186	CbGeAlD
Levothyroxine—TTR—female reproductive system—skin cancer	0.00134	0.0183	CbGeAlD
Levothyroxine—Gastrointestinal pain—Vismodegib—skin cancer	0.00131	0.00955	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Imiquimod—skin cancer	0.00131	0.00951	CcSEcCtD
Levothyroxine—Myocardial infarction—Imiquimod—skin cancer	0.0013	0.00945	CcSEcCtD
Levothyroxine—Abdominal pain—Vismodegib—skin cancer	0.00127	0.00923	CcSEcCtD
Levothyroxine—SLCO1C1—head—skin cancer	0.00125	0.0171	CbGeAlD
Levothyroxine—Alopecia—Vemurafenib—skin cancer	0.00123	0.00897	CcSEcCtD
Levothyroxine—SLCO4A1—female reproductive system—skin cancer	0.0012	0.0164	CbGeAlD
Levothyroxine—Coma—Fluorouracil—skin cancer	0.0012	0.0087	CcSEcCtD
Levothyroxine—Asthenia—Vismodegib—skin cancer	0.00115	0.00838	CcSEcCtD
Levothyroxine—SLC7A5—head—skin cancer	0.00115	0.0157	CbGeAlD
Levothyroxine—Pruritus—Vismodegib—skin cancer	0.00114	0.00826	CcSEcCtD
Levothyroxine—TTR—head—skin cancer	0.00112	0.0152	CbGeAlD
Levothyroxine—Flushing—Imiquimod—skin cancer	0.0011	0.00804	CcSEcCtD
Levothyroxine—Diarrhoea—Vismodegib—skin cancer	0.0011	0.00799	CcSEcCtD
Levothyroxine—Arrhythmia—Imiquimod—skin cancer	0.00106	0.00774	CcSEcCtD
Levothyroxine—Disorientation—Fluorouracil—skin cancer	0.00106	0.00773	CcSEcCtD
Levothyroxine—SLCO1B1—female reproductive system—skin cancer	0.00105	0.0144	CbGeAlD
Levothyroxine—THRA—lymph node—skin cancer	0.00105	0.0144	CbGeAlD
Levothyroxine—THRB—lymph node—skin cancer	0.00105	0.0144	CbGeAlD
Levothyroxine—Alopecia—Imiquimod—skin cancer	0.00105	0.00765	CcSEcCtD
Levothyroxine—Arthralgia—Vemurafenib—skin cancer	0.00103	0.00752	CcSEcCtD
Levothyroxine—Vomiting—Vismodegib—skin cancer	0.00102	0.00742	CcSEcCtD
Levothyroxine—Affect lability—Temozolomide—skin cancer	0.00101	0.00738	CcSEcCtD
Levothyroxine—Rash—Vismodegib—skin cancer	0.00101	0.00736	CcSEcCtD
Levothyroxine—Dermatitis—Vismodegib—skin cancer	0.00101	0.00735	CcSEcCtD
Levothyroxine—SLCO4A1—head—skin cancer	0.001	0.0137	CbGeAlD
Levothyroxine—Dysphagia—Dactinomycin—skin cancer	0.000985	0.00717	CcSEcCtD
Levothyroxine—Mood swings—Temozolomide—skin cancer	0.000977	0.00711	CcSEcCtD
Levothyroxine—Cardiac failure—Fluorouracil—skin cancer	0.000973	0.00708	CcSEcCtD
Levothyroxine—Dehydration—Temozolomide—skin cancer	0.000959	0.00698	CcSEcCtD
Levothyroxine—Weight decreased—Bleomycin—skin cancer	0.000956	0.00695	CcSEcCtD
Levothyroxine—Nausea—Vismodegib—skin cancer	0.000953	0.00694	CcSEcCtD
Levothyroxine—SLC16A2—lymph node—skin cancer	0.000953	0.013	CbGeAlD
Levothyroxine—Agitation—Imiquimod—skin cancer	0.000952	0.00693	CcSEcCtD
Levothyroxine—Angioedema—Imiquimod—skin cancer	0.000947	0.00689	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Bleomycin—skin cancer	0.000929	0.00675	CcSEcCtD
Levothyroxine—Myocardial infarction—Bleomycin—skin cancer	0.000923	0.00672	CcSEcCtD
Levothyroxine—Palpitations—Imiquimod—skin cancer	0.000916	0.00666	CcSEcCtD
Levothyroxine—Muscular weakness—Temozolomide—skin cancer	0.000909	0.00662	CcSEcCtD
Levothyroxine—Irritability—Fluorouracil—skin cancer	0.000907	0.0066	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000903	0.00657	CcSEcCtD
Levothyroxine—Cardiac arrest—Fluorouracil—skin cancer	0.000903	0.00657	CcSEcCtD
Levothyroxine—Convulsion—Imiquimod—skin cancer	0.000898	0.00653	CcSEcCtD
Levothyroxine—Dysphagia—Temozolomide—skin cancer	0.000891	0.00648	CcSEcCtD
Levothyroxine—Arthralgia—Imiquimod—skin cancer	0.000882	0.00642	CcSEcCtD
Levothyroxine—Anxiety—Imiquimod—skin cancer	0.000879	0.00639	CcSEcCtD
Levothyroxine—SLCO1C1—lymph node—skin cancer	0.000875	0.0119	CbGeAlD
Levothyroxine—Sweating increased—Temozolomide—skin cancer	0.000868	0.00631	CcSEcCtD
Levothyroxine—Fatigue—Vemurafenib—skin cancer	0.000855	0.00622	CcSEcCtD
Levothyroxine—Muscular weakness—Fluorouracil—skin cancer	0.000838	0.0061	CcSEcCtD
Levothyroxine—Shock—Imiquimod—skin cancer	0.000832	0.00605	CcSEcCtD
Levothyroxine—Tachycardia—Imiquimod—skin cancer	0.000825	0.006	CcSEcCtD
Levothyroxine—Dysphagia—Fluorouracil—skin cancer	0.000821	0.00597	CcSEcCtD
Levothyroxine—Hyperhidrosis—Imiquimod—skin cancer	0.000817	0.00595	CcSEcCtD
Levothyroxine—Weight decreased—Temozolomide—skin cancer	0.000806	0.00586	CcSEcCtD
Levothyroxine—SLC7A5—lymph node—skin cancer	0.000803	0.011	CbGeAlD
Levothyroxine—Angina pectoris—Fluorouracil—skin cancer	0.0008	0.00582	CcSEcCtD
Levothyroxine—ABCB1—blood vessel—skin cancer	0.000795	0.0109	CbGeAlD
Levothyroxine—Flushing—Bleomycin—skin cancer	0.000785	0.00571	CcSEcCtD
Levothyroxine—Body temperature increased—Vemurafenib—skin cancer	0.000784	0.0057	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00077	0.0056	CcSEcCtD
Levothyroxine—Insomnia—Imiquimod—skin cancer	0.000765	0.00556	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Docetaxel—skin cancer	0.000756	0.0055	CcSEcCtD
Levothyroxine—Dyspnoea—Imiquimod—skin cancer	0.000754	0.00548	CcSEcCtD
Levothyroxine—Alopecia—Bleomycin—skin cancer	0.000747	0.00544	CcSEcCtD
Levothyroxine—Flushing—Dactinomycin—skin cancer	0.000732	0.00532	CcSEcCtD
Levothyroxine—Fatigue—Imiquimod—skin cancer	0.000729	0.0053	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000722	0.00525	CcSEcCtD
Levothyroxine—Myocardial infarction—Fluorouracil—skin cancer	0.000718	0.00522	CcSEcCtD
Levothyroxine—SLCO1A2—head—skin cancer	0.000717	0.00979	CbGeAlD
Levothyroxine—Asthenia—Vemurafenib—skin cancer	0.000711	0.00518	CcSEcCtD
Levothyroxine—Cardiac failure—Docetaxel—skin cancer	0.000703	0.00511	CcSEcCtD
Levothyroxine—Pruritus—Vemurafenib—skin cancer	0.000702	0.0051	CcSEcCtD
Levothyroxine—SLCO4A1—lymph node—skin cancer	0.000701	0.00957	CbGeAlD
Levothyroxine—Alopecia—Dactinomycin—skin cancer	0.000697	0.00507	CcSEcCtD
Levothyroxine—Feeling abnormal—Imiquimod—skin cancer	0.000697	0.00507	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Imiquimod—skin cancer	0.000691	0.00503	CcSEcCtD
Levothyroxine—Diarrhoea—Vemurafenib—skin cancer	0.000678	0.00494	CcSEcCtD
Levothyroxine—Urticaria—Imiquimod—skin cancer	0.000672	0.00489	CcSEcCtD
Levothyroxine—Abdominal pain—Imiquimod—skin cancer	0.000668	0.00486	CcSEcCtD
Levothyroxine—Body temperature increased—Imiquimod—skin cancer	0.000668	0.00486	CcSEcCtD
Levothyroxine—Flushing—Temozolomide—skin cancer	0.000662	0.00482	CcSEcCtD
Levothyroxine—Dehydration—Docetaxel—skin cancer	0.000638	0.00464	CcSEcCtD
Levothyroxine—Vomiting—Vemurafenib—skin cancer	0.00063	0.00459	CcSEcCtD
Levothyroxine—Alopecia—Temozolomide—skin cancer	0.00063	0.00459	CcSEcCtD
Levothyroxine—Rash—Vemurafenib—skin cancer	0.000625	0.00455	CcSEcCtD
Levothyroxine—Dermatitis—Vemurafenib—skin cancer	0.000625	0.00454	CcSEcCtD
Levothyroxine—Headache—Vemurafenib—skin cancer	0.000621	0.00452	CcSEcCtD
Levothyroxine—Asthenia—Imiquimod—skin cancer	0.000607	0.00441	CcSEcCtD
Levothyroxine—Confusional state—Bleomycin—skin cancer	0.000606	0.00441	CcSEcCtD
Levothyroxine—CYP2C8—female reproductive system—skin cancer	0.000599	0.00819	CbGeAlD
Levothyroxine—Pruritus—Imiquimod—skin cancer	0.000598	0.00435	CcSEcCtD
Levothyroxine—Dysphagia—Docetaxel—skin cancer	0.000593	0.00431	CcSEcCtD
Levothyroxine—Nausea—Vemurafenib—skin cancer	0.000589	0.00428	CcSEcCtD
Levothyroxine—Arrhythmia—Fluorouracil—skin cancer	0.000587	0.00427	CcSEcCtD
Levothyroxine—Tremor—Temozolomide—skin cancer	0.000582	0.00423	CcSEcCtD
Levothyroxine—Alopecia—Fluorouracil—skin cancer	0.000581	0.00422	CcSEcCtD
Levothyroxine—Diarrhoea—Imiquimod—skin cancer	0.000579	0.00421	CcSEcCtD
Levothyroxine—Angina pectoris—Docetaxel—skin cancer	0.000577	0.0042	CcSEcCtD
Levothyroxine—Agitation—Temozolomide—skin cancer	0.000571	0.00415	CcSEcCtD
Levothyroxine—Angioedema—Temozolomide—skin cancer	0.000567	0.00413	CcSEcCtD
Levothyroxine—Palpitations—Temozolomide—skin cancer	0.000549	0.00399	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000547	0.00398	CcSEcCtD
Levothyroxine—Convulsion—Temozolomide—skin cancer	0.000538	0.00391	CcSEcCtD
Levothyroxine—Vomiting—Imiquimod—skin cancer	0.000538	0.00391	CcSEcCtD
Levothyroxine—Weight decreased—Docetaxel—skin cancer	0.000536	0.0039	CcSEcCtD
Levothyroxine—Dyspnoea—Bleomycin—skin cancer	0.000536	0.0039	CcSEcCtD
Levothyroxine—Rash—Imiquimod—skin cancer	0.000533	0.00388	CcSEcCtD
Levothyroxine—Dermatitis—Imiquimod—skin cancer	0.000533	0.00388	CcSEcCtD
Levothyroxine—Headache—Imiquimod—skin cancer	0.00053	0.00385	CcSEcCtD
Levothyroxine—Arthralgia—Temozolomide—skin cancer	0.000529	0.00385	CcSEcCtD
Levothyroxine—Anxiety—Temozolomide—skin cancer	0.000527	0.00383	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Docetaxel—skin cancer	0.000521	0.00379	CcSEcCtD
Levothyroxine—Myocardial infarction—Docetaxel—skin cancer	0.000518	0.00377	CcSEcCtD
Levothyroxine—Confusional state—Temozolomide—skin cancer	0.000511	0.00372	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00051	0.00371	CcSEcCtD
Levothyroxine—Nausea—Imiquimod—skin cancer	0.000502	0.00365	CcSEcCtD
Levothyroxine—ALB—lymph node—skin cancer	0.000499	0.00681	CbGeAlD
Levothyroxine—Convulsion—Fluorouracil—skin cancer	0.000496	0.00361	CcSEcCtD
Levothyroxine—Feeling abnormal—Bleomycin—skin cancer	0.000495	0.0036	CcSEcCtD
Levothyroxine—Hyperhidrosis—Temozolomide—skin cancer	0.00049	0.00356	CcSEcCtD
Levothyroxine—Fatigue—Dactinomycin—skin cancer	0.000483	0.00351	CcSEcCtD
Levothyroxine—Urticaria—Bleomycin—skin cancer	0.000477	0.00347	CcSEcCtD
Levothyroxine—Body temperature increased—Bleomycin—skin cancer	0.000475	0.00345	CcSEcCtD
Levothyroxine—Confusional state—Fluorouracil—skin cancer	0.000471	0.00342	CcSEcCtD
Levothyroxine—Feeling abnormal—Dactinomycin—skin cancer	0.000462	0.00336	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000462	0.00336	CcSEcCtD
Levothyroxine—Insomnia—Temozolomide—skin cancer	0.000458	0.00333	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000458	0.00333	CcSEcCtD
Levothyroxine—Tachycardia—Fluorouracil—skin cancer	0.000456	0.00332	CcSEcCtD
Levothyroxine—Dyspnoea—Temozolomide—skin cancer	0.000452	0.00329	CcSEcCtD
Levothyroxine—Abdominal pain—Dactinomycin—skin cancer	0.000443	0.00322	CcSEcCtD
Levothyroxine—Body temperature increased—Dactinomycin—skin cancer	0.000443	0.00322	CcSEcCtD
Levothyroxine—Flushing—Docetaxel—skin cancer	0.00044	0.0032	CcSEcCtD
Levothyroxine—Fatigue—Temozolomide—skin cancer	0.000437	0.00318	CcSEcCtD
Levothyroxine—Asthenia—Bleomycin—skin cancer	0.000431	0.00314	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000425	0.00309	CcSEcCtD
Levothyroxine—Pruritus—Bleomycin—skin cancer	0.000425	0.00309	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—skin cancer	0.000424	0.00308	CcSEcCtD
Levothyroxine—Insomnia—Fluorouracil—skin cancer	0.000422	0.00307	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—skin cancer	0.000419	0.00305	CcSEcCtD
Levothyroxine—Feeling abnormal—Temozolomide—skin cancer	0.000418	0.00304	CcSEcCtD
Levothyroxine—Dyspnoea—Fluorouracil—skin cancer	0.000416	0.00303	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Temozolomide—skin cancer	0.000414	0.00301	CcSEcCtD
Levothyroxine—CYP3A4—female reproductive system—skin cancer	0.000406	0.00554	CbGeAlD
Levothyroxine—Urticaria—Temozolomide—skin cancer	0.000403	0.00293	CcSEcCtD
Levothyroxine—Asthenia—Dactinomycin—skin cancer	0.000402	0.00292	CcSEcCtD
Levothyroxine—Body temperature increased—Temozolomide—skin cancer	0.000401	0.00291	CcSEcCtD
Levothyroxine—Abdominal pain—Temozolomide—skin cancer	0.000401	0.00291	CcSEcCtD
Levothyroxine—ABCB1—epithelium—skin cancer	0.000387	0.00528	CbGeAlD
Levothyroxine—Feeling abnormal—Fluorouracil—skin cancer	0.000385	0.0028	CcSEcCtD
Levothyroxine—Diarrhoea—Dactinomycin—skin cancer	0.000383	0.00279	CcSEcCtD
Levothyroxine—Vomiting—Bleomycin—skin cancer	0.000382	0.00278	CcSEcCtD
Levothyroxine—Rash—Bleomycin—skin cancer	0.000379	0.00276	CcSEcCtD
Levothyroxine—Dermatitis—Bleomycin—skin cancer	0.000378	0.00275	CcSEcCtD
Levothyroxine—Urticaria—Fluorouracil—skin cancer	0.000371	0.0027	CcSEcCtD
Levothyroxine—Body temperature increased—Fluorouracil—skin cancer	0.000369	0.00269	CcSEcCtD
Levothyroxine—Palpitations—Docetaxel—skin cancer	0.000365	0.00265	CcSEcCtD
Levothyroxine—Asthenia—Temozolomide—skin cancer	0.000364	0.00264	CcSEcCtD
Levothyroxine—Pruritus—Temozolomide—skin cancer	0.000359	0.00261	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—skin cancer	0.000358	0.0026	CcSEcCtD
Levothyroxine—Nausea—Bleomycin—skin cancer	0.000357	0.0026	CcSEcCtD
Levothyroxine—Vomiting—Dactinomycin—skin cancer	0.000356	0.00259	CcSEcCtD
Levothyroxine—Rash—Dactinomycin—skin cancer	0.000353	0.00257	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—skin cancer	0.000352	0.00256	CcSEcCtD
Levothyroxine—Diarrhoea—Temozolomide—skin cancer	0.000347	0.00252	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—skin cancer	0.00034	0.00247	CcSEcCtD
Levothyroxine—ABCB1—mammalian vulva—skin cancer	0.000336	0.00458	CbGeAlD
Levothyroxine—Nausea—Dactinomycin—skin cancer	0.000333	0.00242	CcSEcCtD
Levothyroxine—Shock—Docetaxel—skin cancer	0.000332	0.00241	CcSEcCtD
Levothyroxine—Pruritus—Fluorouracil—skin cancer	0.00033	0.0024	CcSEcCtD
Levothyroxine—Tachycardia—Docetaxel—skin cancer	0.000329	0.00239	CcSEcCtD
Levothyroxine—Vomiting—Temozolomide—skin cancer	0.000322	0.00234	CcSEcCtD
Levothyroxine—Rash—Temozolomide—skin cancer	0.00032	0.00232	CcSEcCtD
Levothyroxine—Diarrhoea—Fluorouracil—skin cancer	0.000319	0.00232	CcSEcCtD
Levothyroxine—Dermatitis—Temozolomide—skin cancer	0.000319	0.00232	CcSEcCtD
Levothyroxine—Headache—Temozolomide—skin cancer	0.000317	0.00231	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000307	0.00223	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—skin cancer	0.000305	0.00222	CcSEcCtD
Levothyroxine—Nausea—Temozolomide—skin cancer	0.000301	0.00219	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—skin cancer	0.0003	0.00219	CcSEcCtD
Levothyroxine—ABCB1—lymphoid tissue—skin cancer	0.000298	0.00407	CbGeAlD
Levothyroxine—Vomiting—Fluorouracil—skin cancer	0.000297	0.00216	CcSEcCtD
Levothyroxine—Rash—Fluorouracil—skin cancer	0.000294	0.00214	CcSEcCtD
Levothyroxine—Dermatitis—Fluorouracil—skin cancer	0.000294	0.00214	CcSEcCtD
Levothyroxine—Headache—Fluorouracil—skin cancer	0.000293	0.00213	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—skin cancer	0.000291	0.00211	CcSEcCtD
Levothyroxine—ABCB1—female reproductive system—skin cancer	0.000287	0.00392	CbGeAlD
Levothyroxine—Feeling abnormal—Docetaxel—skin cancer	0.000278	0.00202	CcSEcCtD
Levothyroxine—Nausea—Fluorouracil—skin cancer	0.000277	0.00202	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Docetaxel—skin cancer	0.000276	0.002	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—skin cancer	0.000266	0.00194	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—skin cancer	0.000266	0.00194	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—skin cancer	0.000242	0.00176	CcSEcCtD
Levothyroxine—ABCB1—head—skin cancer	0.00024	0.00328	CbGeAlD
Levothyroxine—Pruritus—Docetaxel—skin cancer	0.000238	0.00173	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—skin cancer	0.000231	0.00168	CcSEcCtD
Levothyroxine—Vomiting—Docetaxel—skin cancer	0.000214	0.00156	CcSEcCtD
Levothyroxine—Rash—Docetaxel—skin cancer	0.000212	0.00155	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—skin cancer	0.000212	0.00154	CcSEcCtD
Levothyroxine—Headache—Docetaxel—skin cancer	0.000211	0.00154	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—skin cancer	0.0002	0.00146	CcSEcCtD
Levothyroxine—ABCB1—lymph node—skin cancer	0.000168	0.0023	CbGeAlD
